Amanote Research
Register
Sign In
Direct Non-Medical Costs of Rheumatoid Arthritis by Disease Level in Portugal
Value in Health
- United Kingdom
doi 10.1016/j.jval.2014.08.2590
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Date
November 1, 2014
Authors
C. Mateus
A. Moura
Publisher
Elsevier BV
Related search
Utility and Direct Costs: Ankylosing Spondylitis Compared With Rheumatoid Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis
Journal of managed care & specialty pharmacy
Health Policy
Pharmacy
Pharmaceutical Science
Productivity Loss of Rheumatoid Arthritis Patients by Their Level of Disease Activity Score
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-World Analysis of Nationwide Japanese Claims Data
Clinical Therapeutics
Pharmacology
Disease Assessment in Rheumatoid Arthritis.
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Remission in Rheumatoid Arthritis: Benefit Over Low Disease Activity in Patient-Reported Outcomes and Costs
Arthritis Research and Therapy
Rheumatology
Allergy
Immunology
PIN73 Direct Medical Costs and Health Care Resource Use Associated With Hepatis C Infection in Portugal
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Rheumatoid Arthritis and Cardiovascular Disease
Current Opinion in Rheumatology
Rheumatology
Anaemia of Chronic Disease in Rheumatoid Arthritis
Rheumatology International
Rheumatology
Allergy
Immunology
